Lactoperoxidase (LPO) is a component of milk and other external secretions. To study the influence of ingested LPO on the digestive tract, we performed DNA microarray analysis of the small intestine of mice administered LPO. LPO administration upregulated 78 genes, including genes involved in metabolism, immunity, apoptosis, and the cell cycle, and downregulated nine genes, including immunity-related genes. The most upregulated gene was FK506 binding protein 5 (FKBP5), a glucocorticoid regulating immunophilin. The upregulation of this gene was confirmed by quantitative RT-PCR in other samples. In situ hybridization revealed that expression of the FKBP5 gene in the crypt epithelial cells of the small intestine was enhanced by LPO. These results suggest that ingested LPO modulates gene expression in the small intestine and especially increases FKBP5 gene expression in the epithelial cells of the intestine.
Lactoperoxidase (LPO) is a component of milk and other external secretions. To study the influence of ingested LPO on the digestive tract, we performed DNA microarray analysis of the small intestine of mice administered LPO. LPO administration upregulated 78 genes, including genes involved in metabolism, immunity, apoptosis, and the cell cycle, and downregulated nine genes, including immunity-related genes. The most upregulated gene was FK506 binding protein 5 (FKBP5), a glucocorticoid regulating immunophilin. The upregulation of this gene was confirmed by quantitative RT-PCR in other samples. In situ hybridization revealed that expression of the FKBP5 gene in the crypt epithelial cells of the small intestine was enhanced by LPO. These results suggest that ingested LPO modulates gene expression in the small intestine and especially increases FKBP5 gene expression in the epithelial cells of the intestine.
Key words: lactoperoxidase; small intestine; DNA microarray; FK506 binding protein 5; epithelial cells Lactoperoxidase (LPO), a heme-containing glycoprotein of the mammalian peroxidase family, is a component of milk, saliva, airway mucus, and other exocrine secretions. 1, 2) LPO is an enzyme that catalyses the hydrogen peroxide (H 2 O 2 )-dependent oxidation of thiocyanate (SCN À ) to produce the hypothiocyanate anion (OSCN À ), which has inhibitory activity against a wide variety of microorganisms, including gram-positive and gram-negative bacteria, fungi, and viruses. 3, 4) The in vivo antibacterial activity of LPO and its substrates has been demonstrated in the sheep airway. 5) Direct antimicrobial effects in the oral cavity and gastrointestinal tract have been achieved by orally administered LPO. 6, 7) In addition, LPO exerts immunomodulatory effects. It stimulates functions of macrophages, including respiratory burst, cytotoxicity, and tumor necrosis factor production in vitro. 8, 9) It inhibits the production of interferon-(IFN-) from mitogen-stimulated sheep lymphocytes in vitro. 10) Reduced lymphocyte output and lymph flow rate from the local lymph nodes have also been observed in sheep after LPO was injected subcutaneously. 11) There have been few reports on the physiological effects of orally administered LPO, but we recently examined the effect of LPO treatment in a model of pneumonia caused by influenza virus infection in mice.
12) The yield of virus in the bronchoalveolar lavage fluid (BALF) was not affected by LPO treatment, but LPO administration reduced the interleukin (IL)-6 level in the serum, the lung consolidation score, and the number of infiltrated leukocytes in BALF on day 6 after infection, when the virus titer was already low but the symptoms were still severe. These findings suggest that oral administration of LPO exerts antiinflammatory effects and improves the outcome of the disease.
We hypothesized that ingested LPO acts primarily on the intestinal tissues, inducing effects that might include transcriptional modulation of genes, and thereby exerts its physiological effects, since LPO has a molecular weight of 80 kDa and might not be transferred to the blood circulation. To explore the functions of LPO in intestinal tissues comprehensively, we performed gene expression profiling in LPO-administered mice by DNA y To whom correspondence should be addressed. Fax: +81-46-252-3059; E-mail: h wakaby@morinagamilk.co.jp Abbreviations: LPO, lactoperoxidase; FKBP5, FK506 binding protein 5; H 2 O 2 , hydrogen peroxide; IFN-, interferon-; BALF, bronchoalveolar lavage fluid; IL, interleukin; BSA, bovine serum albumin; GEO, Gene Expression Omnibus database; GO, Gene Ontology; ACTB, -actin; DIG, digoxigenin; CXCL10, chemokine (C-X-C motif) ligand 10; IEL, intraepithelial lymphocyte; CTL, cytotoxic T cell; IBD, inflammatory bowel disease; NO, nitric oxide microarray analysis. Then we chose the most upregulated gene FK506 binding protein 5, FKBP5, and further studied the effect of LPO on its expression.
Materials and Methods
Materials. Bovine serum albumin (BSA) of proteaseand -globulin-free grade was purchased from Sigma (Saint Louis, MO). Crude bovine LPO with a purity of 89.0% was prepared from fresh skim milk by cationexchange chromatography according to a published procedure. 13) For further purification, 100 g of the crude LPO preparation was dissolved in deionized water and applied to a glass column containing a resin of SP Sepharose Fast Flow (Amersham Biosciences, Piscataway, NJ). The column was washed with 11 liters of 20 mM sodium phosphate buffer, pH 6.4, and then 11 litters of the buffer containing 0.15 M NaCl. LPO was eluted from the column with 7 litters of this buffer containing 0.3 M NaCl. The purified LPO solution was desalted and concentrated using an ultrafiltration membrane module with a molecular cut-off size of 10,000 (Asahi Kasei, Osaka, Japan), sterilized by filtration through a membrane with a pore size of 0.45 mm (Nalge Nunc International, Rochester, NY), and freeze-dried. LPO with a purity of 98.9% was thereby obtained.
Animal experiments. SPF female BALB/cByJ Jcl mice bred on diet CE-2 (Clea Japan, Tokyo) were used for animal experiments at 8 to 9 weeks of age. The mice were allowed free access to a standard commercial diet (Labo MR stock, Nosan Corporation, Yokohama, Japan) and tap water. Diet CE-2 and Labo MR stock are both free from bovine materials such as milk products, LPO, and BSA. The mice were orally administered 200 ml of water, BSA (2.5 g/kg body weight) solution, or LPO (2.5 g/kg body weight) solution by gavage. This administration doze was determined based on our previous study of an influenza virus pneumonia model, in which we administered 62.5 mg/mouse of LPO, equivalent to 3.1 g/kg. 12) One or 3 h after administration of the test compound, a 2-cm length of jejunum detached Peyer's patch was dissected, washed in PBS with 10 mM EDTA, immersed in RNAlater (Ambion, Austin, TX), and stored at À80 C until RNA extraction. For in situ hybridization, the ileum was dissected 3 h after administration of the test compound, cut longitudinally, fixed in tissue fixative (Genostaff, Tokyo), washed in PBS, and stored in 70% ethanol at 4 C. All animal studies were approved by the Morinaga Milk Industry Animal Research Committee, and the mice were maintained according to the guidelines for the care and use of laboratory animals of Morinaga Milk Industry.
RNA isolation. Total RNA was extracted from the intestinal tissue by homogenization in TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Then the RNA was cleaned using an RNeasy Mini Kit (Qiagen, Hilden, Germany). The amounts of RNA in the samples were quantified by measuring OD 260/280 nm , and the quality of the RNA was verified by analysis of 18S and 28S ribosomal RNAs bands after agarose gel electrophoresis.
Microarray experiments. Eight micrograms of RNA were reverse-transcribed into cDNA using Superscript II (Invitrogen) with a T7-(dT) 24 oligomer to prime firststrand synthesis, and the product was incubated with DNA polymerase and DNA ligase for synthesis of the second strand. Following cleanup, cDNA was used as the template for synthesis of biotin-labeled cRNA with GeneChip Expression 3 0 -Amplification Reagents for IVT Labeling (Affymetrix, Santa Clara, CA), and the labeled cRNA was subjected to fragmentation prior to hybridization. The GeneChip Mouse Genome 430 2.0 Array (Affymetrix) was used for gene expression profiling. This array represents more than 39,000 transcripts and variants, including more than 34,000 wellcharacterized mouse genes. Arrays were hybridized with 15 mg of fragmented cRNA in a hybridization cocktail in a hybridization oven at 60 rpm and 45 C for 16 h. Washing and staining of arrays were performed using the GeneChip Fluidics Station 400 (Affymetrix). Each array was washed repeatedly with wash buffers, stained with a streptavidin phycoerythrin (Molecular Probes, Leiden, Netherlands) solution, and then reacted with biotinylated anti-streptavidin antibody and streptavidin phycoerythrin, prior to being scanned with a GeneChip Scanner 3000 (Affymetrix).
Analysis of microarray data. The microarray experiments were done in triplicate from three animals, yielding a total of nine array data sets for animals treated with water (n ¼ 3), BSA (n ¼ 3), or LPO (n ¼ 3). Data from the nine hybridizations were processed using GeneChip Operating Software Version 5.0 (Affymetrix). Hybridization data have been submitted to the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus database (GEO; http:// www.ncbi.nlm.nih.gov/geo) under GEO accession no. GSE5562. For comparison of data on separate microarrays, the intensity values of each array were first normalized by all probe sets against one water array. To identify intestinal genes differentially expressed in response to ingestion of LPO, comparison analysis of the three LPO arrays was done against the three water arrays (a total of nine comparisons) or against the three BSA arrays (a total of nine comparisons) by the normalization method. The change call, increase, marginal increase, no change, marginal decrease, or decrease, was obtained for all probe sets by comparison analysis. Probe sets judged to show ''increase'' or ''decrease'' in four to nine comparisons of a total of nine comparisons were selected as increased or decreased genes respectively. Second, selected probe sets were analyzed statistically by analysis of variance and post hoc Tukey's test between LPO and water, and also LPO and BSA, using Excel software (Microsoft, Tokyo). Probe sets that met the criterion of P < 0:05 were considered to show significant change. Finally, probe sets of LPO that showed significant increases or decreases as compared with those of both water and BSA were identified as increased or decreased genes. Gene Ontology (GO) information was obtained from the NetAffx Analysis Center (Affymetrix; http://www. affymetrix.com) and used for classification of genes involved in biological processes or coding for cellular components.
Cell culture. The rat small intestinal epithelial cell line IEC-6 (ATCC CRL 1592), which was established by Quaroni et al., 14) was purchased from Dainippon Sumitomo Pharma (Osaka, Japan) and routinely cultured in DMEM (Sigma) containing 10% FCS (Invitrogen) in a humidified atmosphere consisting of 5% CO 2 and 95% air at 37
C. IEC-6 cells were obtained from stock cultures after incubation with 0.02% EDTA solution and with 0.25% trypsin solution (Sigma). Cells were washed and resuspended in DMEM containing 10% FCS at 5 Â 10 4 cells/ml. Three milliliters of the cell suspension were added to each well of a 6-well culture plate (BD Falcon, Tokyo) and cultured for 24 to 48 h. The cells were cultured for 48 h to achieve 90% confluence. Then the medium was replaced with DMEM containing 10% FCS with or without the test agent. BSA or LPO was added to the culture medium as a test agent at concentrations of 5 and 50 mg/ml. Experiments were performed in triplicate for each condition. After culturing for 3 h, the cells in each well were lysed with 1 ml of TRIzol reagent, and total RNA was isolated.
Quantitative RT-PCR. cDNA synthesis was performed with an Advantage RT-for-PCR Kit (BD Biosiences Clontech, Palo Alto, CA) using 1 mg of total RNA and 20 pmol of oligo(dT) 18 primer, as described previously. 15) cDNA solutions were diluted 1/10, and 5 ml of the diluted cDNA was added to 20 ml of PCR reaction mixture containing 12.5 ml of TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA) and 1.25 ml each of TaqMan Gene Expression Assays (primer pair and probe set, Applied Biosystems). The number of TaqMan Gene Expression Assays used was as follows: Mm00607939 s1 for mouse -actin (ACTB), Mm00487401 m1 for mouse FKBP5, Rn00667869 m1 for rat ACTB, and Rn01768379 m1 for rat FKBP5. Reactions were conducted in a MicroAmp Optical 96-Well Reaction Plate (Applied Biosystems) in a 7500 Fast Real Time PCR System (Applied Biosystems). Following UNG activation at 50 C for 2 min and AmpliTaq activation at 95 C for 10 min, 40 cycles of amplification with each cycle consisting of two steps, 95 C for 15 s and 60 C for 1 min, were performed. For real-time analysis, cDNA levels of samples were quantified by comparison with a standard curve generated by amplifying serial 5-fold dilutions of a nondiluted cDNA template with the corresponding primer/ probe set. Relative gene expression units were calculated by normalization, in which the value for the target gene was divided by the value for the ACTB gene.
In situ hybridization. Mouse FKBP5 cDNA, corresponding to base pairs 490-859 of GenBank accession no. NM 010220, was subcloned into pGEM-T vector (Promega, Madison, WI) and used for generation of sense and antisense RNA probes. Digoxigenin (DIG) labeled-RNA probes were prepared with DIG RNA labeling Mix (Roche Diagnostics, Tokyo). The intestinal tissue was embedded in paraffin and sectioned at 6 mm. Tissue sections were de-waxed with xylene and rehydrated through an ethanol series and PBS. The sections were fixed with 4% paraformaldehyde in PBS for 15 min, treated with 10 mg/ml proteinase K, refixed with 4% paraformaldehyde in PBS, and placed in 0.2 M HCl for 10 min. Then they were acetylated by incubation with 0.1 M triethanolamine-HCl, pH 8.0, and 0.25% acetic anhydride for 10 min and dehydrated with a graded series of ethanol concentrations. Hybridization was performed with probes at 100 ng/ml in the Probe Diluent (Genostaff) at 60 C for 16 h. After hybridization, the sections were washed in 5ÂHybriWash (Genostaff), and then in 50% formamide and 2ÂHybri-Wash, and treated with RNase A at 50 mg/ml. Then the sections were washed, treated with 0.5% blocking reagent (Roche), and incubated for 2 h with alkaline phosphatase-conjugated anti-DIG antibody (Roche) (1:1,000 dilution). After washing, coloring reactions were performed with BM purple alkaline phosphatase substrate (Roche) overnight. The sections were counterstained with Kernechtrot stain solution (Muto Pure Chemicals, Tokyo), which mainly stains the nucleus, and dehydrated and mounted with Malinol (Muto).
Statistical analysis. Data for quantitative RT-PCR were expressed as mean AE SEM. Statistical analysis was done by two-tailed Student's t test using Excel. P < 0:05 and < 0:10 were considered to indicate significant differences and a tendency to be different respectively.
Results

Microarray analysis of intestinal gene expression modulated by LPO administration
To identify genes that were transcriptionally modulated in the small intestine by LPO, mice were orally administered water (n ¼ 3), BSA (n ¼ 3), or LPO (n ¼ 3), and after 3 h, total RNA from the jejunum was subjected to microarray analysis. The numbers of probe sets that showed significant increases in the LPO group in comparison with the water and BSA groups were 199 and 162 respectively. The number of probe sets that showed significant increases in the LPO group as compared to the water and BSA groups was 94. After The listed genes were significantly upregulated 3 h after LPO administration as compared with water and BSA administration. The genes were categorized as being involved in metabolism, immunity, apoptosis, cell cycle, transcriptional regulation, signal transduction, protein modification, or cell movement, or being a cell membrane protein or nuclear protein. The fold change shown represents the average expression level of LPO-fed mice (n ¼ 3) as compared with water (W)-fed mice (n ¼ 3) and BSA-fed mice (n ¼ 3).
integration of multiple probe sets for a single gene, 78 genes were identified as being upregulated by LPO. These upregulated genes were categorized basically according to the GO biological process or the GO cellular component into metabolism (11 genes), immunity (10 genes), apoptosis (10 genes), cell cycle (seven genes), transcriptional regulation (five genes), signal transduction (three genes), protein modification (three genes), cell movement (two genes), cell membrane protein (three genes), nuclear protein (one gene) (Table 1) , and others, including unknown functions (23 genes) (data not shown). The fold increase was comparable for the LPO/water comparison and LPO/ BSA comparison. The most highly increased gene was FKBP5, whose expression was 4.91-and 4.86-fold higher in LPO-administered mice as compared to waterand BSA-administered mice respectively. The numbers of probe sets that showed significant decreases in the LPO group as compared with the water and BSA groups were 86 and 28 respectively. The number of probe sets that showed significant decreases in the LPO group in comparison with the water and BSA groups was nine, representing nine genes. These downregulated genes were categorized basically according to the GO biological process or the GO cellular component into immunity (three genes), metabolism (one gene), transcriptional regulation (one gene), extracellular protein (two genes), and others, including unknown function (two genes) ( Table 2 ). The most markedly decreased gene was chemokine (C-X-C motif) ligand 10 (CXCL10), whose expression was changed by 0.45-and 0.43-fold in LPO-administered mice as compared to water-and BSA-administered mice respectively.
Quantitative RT-PCR analysis of FKBP5 gene expression
The gene expression of FKBP5 was most markedly increased by LPO administration, as demonstrated by microarray analysis. To verify the reproducibility of the gene-expression change observed at 3 h after administration by microarray analysis and to determine whether there was an even earlier response in the expression of the gene, we performed quantitative RT-PCR of samples derived from another animal experiment. The analysis was done at 1 h and 3 h after administration in wateradministered mice (n ¼ 5) and LPO-administered mice (n ¼ 5). FKBP5 gene expression showed a significant increase 3 h after LPO administration (Fig. 1A) . Even 1 h after LPO administration, expression of FKBP5 showed a tendency to increase (Fig. 1A) .
Gene expression of FKBP5 in a rat intestinal epithelial cell line
The effect of LPO on the gene expression of FKBP5 was examined using a rat intestinal epithelial cell line in vitro. IEC-6 cells were incubated with BSA or LPO at 5 or 50 mg/ml for 3 h, and then the gene expression of FKBP5 was examined by quantitative RT-PCR. LPO added at 50 mg/ml significantly enhanced the expression of the FKBP5 gene in IEC-6 cells in comparison with the medium control and 50 mg/ml of BSA (Fig. 1B) . BSA did not alter FKBP5 gene expression.
Localization of FKBP5 mRNA expression in the small intestine
Using in situ hybridization with a DIG-labeled antisense RNA probe, we investigated the localization of FKBP5 expression in the small intestinal tissues, and compared the intensity of the staining in BSA-administered mice and LPO-administered mice. FKBP5 gene expression was found to be limited mainly to epithelial cells in the crypt (Fig. 2) and mononuclear cells in the Peyer's patches (Fig. 3) of the ileum. Positive staining for FKBP5 was observed in crypt epithelial cells, but not The listed genes were significantly downregulated 3 h after LPO administration as compared with water and BSA administration. The genes were categorized as being involved in immunity, metabolism, or transcriptional regulation, or being an extracellular protein or others. The fold change shown represents the average expression level of LPO-fed mice (n ¼ 3) as compared with water (W)-fed mice (n ¼ 3) and BSA-fed mice (n ¼ 3).
in villus epithelial cells ( Fig. 2A, B, C, D) , lamina propria, or Paneth cells containing granules (Fig. 2C,  D) . This suggests that the FKBP5 gene is expressed in relatively immature epithelial cells of the small intestine. FKBP5 expression was also observed in intraepithelial lymphocytes (IELs) of the crypt as well as in epithelial cells (Fig. 2E, F) . Three hours after administration of the test agents, the signal intensity in crypt epithelial cells was stronger in LPO-administered mouse (Fig. 2B, D, F ) than in BSA-administered mouse ( Fig. 2A, C, E) . When the sense probe was used, no positive staining was detected in any of the samples (data not shown). FKBP5-positive staining was also observed in mononuclear cells in Peyer's patches (Fig. 3) . The signal intensity in mononuclear cells of Peyer's patch was comparable as between BSA-administered mouse (Fig. 3A, C) and LPO-administered mouse (Fig. 3B, D) .
Discussion
In this study, we found that orally administered LPO modulates the expression of multiple genes in the small intestine of mice. Microarray analysis indicated that the expression of 78 genes and nine genes was respectively up-and down-regulated 3 h after LPO administration. The number of upregulated genes was larger than that of downregulated genes, suggesting that the general mode of LPO action on the gene expression of the intestine is activation rather than suppression.
Among the upregulated genes, the most abundant groups categorized were metabolism, immunity, apoptosis, and cell cycle. The fact that the small intestine is an important organ in metabolism may help to explain why many metabolism-related genes were modulated. We noted that many cytotoxic T lymphocyte (CTL)-related genes were upregulated by LPO in the immunity and apoptosis categories, including cytotoxic T lymphocyte-associated protein 2 beta (CTLA2B), CD8 antigen alpha chain (CD8A), granzymes (GZMK, GZMB, and GZMA), and T cell receptors (TCRA, LOC381765, and TCRB-V13). Therefore, CTLs may be one of the targets of LPO action in the intestine.
FKBP5 was the gene with the most marked increase of expression at 3 h after LPO administration. FKBP5, formerly called FKBP51, is an immunophilin with peptidylprolyl isomerase activity induced in human T cells by glucocorticoids. 16, 17) Although the physiological role of FKBP5 has not been fully elucidated, it has been reported that it mediates calcineurin inhibition by the immunosuppressive drug FK506 16) and is involved in IKK signaling, 18) and that its polymorphisms are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. 19) It has been reported to be expressed in T cells in mice 16) and in various tissues such as the small intestine and liver in humans. 17) We determined here for the first time the detailed localization of FKBP5 mRNA in the small intestinal compartment of mice. or the difference in species may have affected the result. Nonetheless, these findings suggest that intestinal epithelial cells are a primary target of action of orally administered LPO. Studies of the dose dependency of the oral LPO effect and its effect on protein level of FKBP5 expression are subjects for the future.
We noticed that several LPO-modulated genes are glucocorticoid-regulated genes, like FKBP5. In addition to FKBP5, these genes include serum/glucocorticoid regulated kinase (SGK), DNA-damage-inducible transcript 4 (DDIT4), phosphoenolpyruvate carboxykinase 1 (PCK1), TSC22 domain family 3 (TSC22D3), protein kinase inhibitor gamma (PKIG), and chemokine (C-X-C motif) ligand 10 (CXCL10). LPO-upregulated genes, FKBP5, SGK, DDIT4, PCK1, TSC22D3, and PKIG, are known to be induced by glucocorticoids. 17, [20] [21] [22] [23] [24] The LPO-downregulated gene CXCL10 is known to be suppressed by glucocorticoids. 25) This suggests that orally administered LPO modulates gene expression similarly to glucocorticoids. Subcutaneous injection of a synthetic glucocorticoid dexamethasone promotes functional maturation of the small intestine of infant mice with concomitant transcriptional upregulation of genes such as FKBP5, SGK, and PKIG. 24) Therefore, the effects of LPO on intestinal maturation and turnover are intriguing issues. These concerns are also supported by the result that LPO upregulated many cell-cycle-related genes.
In our previous study, oral administration of LPO was found to exert an anti-inflammatory effect in influenza virus-induced pneumonia in mice. 12) In that study, LPO did not show adverse effects such as increasing the virus titer or decreasing the levels of IFN-and IL-12, which are important in antiviral host protection. Therefore, Mice were administered BSA or LPO, and after 3 h the localization of FKBP5 gene expression (blue) in the ileum was examined by in situ hybridization. All sections were counterstained for the nucleus with Kernechtrot (pink). A, Hybridization of the ileum section from BSAadministered mouse with the FKBP5 antisense probe showed weak staining in the crypt epithelium but not in the villous epithelium. B, Section from LPO-administered mouse showed stronger staining in the crypt epithelium. C, Section at higher magnification from BSA-administered mouse with the antisense probe showed weak staining in epithelial cells, but not in Paneth cells containing granules (arrowheads) or lamina propria (thin arrows) in the crypt. D, Section at higher magnification from LPO-administered mouse showed stronger staining in the epithelial cells, but not in Paneth cells (arrowheads) or lamina propria (thin arrows) of the crypt. Positive staining was also evident in the IEL (thick arrows) and in epithelial cells in the crypt of BSA-administered mice (E) and LPO-administered mice (F) with the antisense probe. The scale bar for all photos is 50 mm.
LPO administration may attenuate inflammatory conditions without suppressing host protective immunity. LPO feeding may also have beneficial effects on other inflammatory conditions. In fact, LPO administration attenuated the severity of colitis induced by dextran sulfate in mice, a model of inflammatory bowel disease (IBD) (K. Shin et al., unpublished results). Since glucocorticoids have antiinflammatory activity, glucocorticoid-regulated genes may relate to these antiinflammatory effects of LPO. The involvement of the LPO-modulated genes identified here in the therapeutic effect of LPO is now being studied in the IBD model. Transcriptional modulation of such genes in the intestine might then affect the intestinal-systemic interactions of the immune, hormonal, and nervous systems.
The enzymatic activity of LPO detoxifies the reactive oxygen species H 2 O 2 by converting it to H 2 O.
3) LPO has also been reported to decrease the level of nitric oxide (NO). 26) Because H 2 O 2 and NO are inflammatory mediators, LPO can exert antiinflammatory effects 27) and modulate gene expression by removing these molecules. Because LPO catalyses peroxidation of thiocyanate and some halides (I À , Br À ), and oxidation of sulphydryl (SH) groups of proteins, 3) the generated products might exhibit glucocorticoid-like activities or modulate the transcriptions, but it is not clear whether LPO retains its enzymatic activity in the digestive tract. Perhaps it is relevant to this issue that a dark brown product originating from the heme structure of LPO was observed even in the lower small intestine after oral administration of LPO. Alternatively, peptide fragments or heme derived from digestion of LPO might directly interact with intestinal cells and modulate cellular functions such as gene expression. It is important to test these possibilities regarding the mechanism of action and further physiological roles of dietary LPO in the body. Mice were administered BSA or LPO, and after 3 h the localization of FKBP5 gene expression (blue) in Peyer's patches of the ileum was examined by in situ hybridization. All sections were counterstained for the nucleus with Kernechtrot (pink). A, Hybridization of ileum section from BSA-administered mouse with FKBP5 antisense probe showed staining in Peyer's patch cells. B, The section from LPO-administered mouse showed staining comparable to (A) in Peyer's patch cells. The section at higher magnification from BSA-administered mouse (C) and LPO-administered mouse (D) with the antisense probe showed comparable staining in mononuclear cells of Peyer's patches. The scale bar for all photos is 50 mm.
